American International Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

American International Group’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-388	Closed	-$52	–	3346
2021 Q1	$52	Buy	388 +1	+0.3%	+$153	﹤0.01%	2978
2020 Q4	$62	Sell	387 -11	-3%	-$1.34K	﹤0.01%	2889
2020 Q3	$42K	Sell	398 -9	-2%	-$1.08K	﹤0.01%	2939
2020 Q2	$49K	Buy	407 +35	+9%	+$3.96K	﹤0.01%	2890
2020 Q1	$29K	Sell	372 -22	-6%	-$3.58K	﹤0.01%	2858
2019 Q4	$116K	Sell	394 -3	-0.8%	-$605	﹤0.01%	2543
2019 Q3	$72K	Buy	397 +36	+10%	+$10.2K	﹤0.01%	2772
2019 Q2	$144K	Buy	361 +3	+0.8%	+$1.26K	﹤0.01%	2447
2019 Q1	$167K	Sell	358 -11	-3%	-$5.34K	﹤0.01%	2310
2018 Q4	$177K	Sell	369 -3	-0.8%	-$1.66K	﹤0.01%	2250
2018 Q3	$254K	Buy	372 +22	+6%	+$14.1K	﹤0.01%	2286
2018 Q2	$239K	Buy	+350	New	+$227K	﹤0.01%	2254

Other funds holding ELOX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American International Group's ELOX Position: Q2 2021 in Review

American International Group sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 388 shares — an estimated $52 sold.

American International Group first reported a position in ELOX in Q2 2018 and held it in 12 quarters. The position peaked at $254K in Q3 2018. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

American International Group reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 388 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $52.
American International Group first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
American International Group's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $254K in Q3 2018.
46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.